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Abstract
Context: The importance of evidence from randomised trials is now widely recognised,
although recruitment is often difficult. Qualitative research has shown promise in
identifying the key barriers to recruitment, and interventions have been developed
to reduce organisational difficulties and support clinicians undertaking recruitment.
Objective: This article provides an introduction to qualitative research techniques and
explains how this approach can be used to understand—and subsequently improve—
recruitment and informed consent within a range of clinical trials.
Evidence acquisition: A literature search was performed using Medline, Embase, and
CINAHL. All studies with qualitative research methods that focused on the recruitment
activity of clinicians were included in the review.
Evidence synthesis: The majority of studies reported that organisational difﬁculties and
lack of time for clinical staff were key barriers to recruitment. However, a synthesis of
qualitative studies highlighted the intellectual and emotional challenges that arise when
combining research with clinical roles, particularly in relation to equipoise and patient
eligibility. To support recruiters to become more comfortable with the design and
principles of randomised controlled trials, interventions have been developed, including
the QuinteT Recruitment Intervention, which comprises in-depth investigation of
recruitment obstacles in real time, followed by implementation of tailored strategies
to address these challenges as the trial proceeds.
Conclusions: Qualitative research can provide important insights into the complexities
of recruitment to trials and inform the development of interventions, and provide
support and training initiatives as required. Investigators should consider implementing
such methods in trials expected to be challenging or recruiting below target.
Patient summary: Qualitative research is a term used to describe a range of methods
that can be implemented to understand participants’ perspectives and behaviours. Data
are gathered from interviews, focus groups, or observations. In this review, we demon-
strate how this approach can be used to understand—and improve—recruitment to
clinical trials. Taken together, our review suggests that healthcare professionals can ﬁnd
recruiting to trials challenging and require support with this process.
# 2017 European Association of Urology. Published by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
* Corresponding author. School of Social and Community Medicine, University of Bristol, Canynge
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1. Introduction
Clinical policy and practice recommend the use of current
best evidence to guide decisions about patient care, which is
essential for providing high-quality healthcare [1]. Random-
ised controlled trials (RCTs) are recognised as the most
effective methodology for the evaluation of the effective-
ness and safety of healthcare interventions [2], especially
when brought together in systematic reviews [3]. However,
the lack of high-quality evidence to support clinical decision
making means that many fundamental questions in
medicine—including in the management of urological
patients—remain unanswered. Guidelines are often based
on expert opinion or weak evidence [4], and new trials are
therefore required to tackle many major questions in
urology. Studies such as the Prostate Cancer Intervention
Versus Observation Trial [5] and the Prostate Testing for
Cancer and Treatment trial (ProtecT) study [6,7] demon-
strate that urological RCTs can be undertaken successfully.
However, less than a third of trials achieve their original
recruitment target [8].
Reviews have reported that successful RCT recruitment
is associated with a number of factors, including addressing
clinically important questions at a timely point, employing
dedicated research staff, ensuring that staff are trained
about trial processes and interventions, and having
straightforward data collection [9,10]. In addition,
effective strategies to improve recruitment include tele-
phone reminders, financial incentives, open-trial designs
where participants know which treatment they are receiv-
ing in the trial, and use of opt-out rather than opt-in
procedures [3]. However, Bower and colleagues [11]
highlighted that there was also a need to develop effective
interventions aimed at those recruiting to trials. Although
patient information leaflets are strictly regulated by ethics
committees, the communication style of the recruiter
(usually a clinician or nurse) plays an important role in
patients’ understanding of the information and their
willingness to join the study [12]. Research has shown
that information conveyed during recruitment appoint-
ments varies considerably in content and quality [13], and
patients often have a poor understanding of RCT concepts
[14–17]. A systematic review of interventions to improve
the recruitment activity of clinicians reported that the most
promising interventions were studies that used qualitative
research to identify key issues and develop interventions to
improve recruitment [18]. This focused review provides
an introduction to qualitative research techniques and
summarises how this approach can be used to understand—
and subsequently improve—recruitment to RCTs.
1.1. Qualitative research
Qualitative research is an umbrella term used for a range of
methodologies used to generate rich accounts of how
people make sense of the world and how they experience
events [19]. Whereas quantitative research focuses on ‘‘how
many’’ and ‘‘how much’’, qualitative research seeks to
answer ‘‘how’’ and ‘‘why’’ questions [20]. Data are primarily
gathered from interviews, focus groups, and observations
intensively in small numbers to facilitate understanding.
Data collection and analysis are iterative processes that
continue until saturation is reached (ie, the point at which
no new themes emerge) [21].
2. Evidence acquisition
This article does not intend to provide a systematic review
of the current literature, but instead highlights ways in
which qualitative methods can be used to understand
recruitment to RCTs. A search of Medline, Embase, and
CINAHL was undertaken in October 2016 using a combina-
tion of the following keywords qualitative, recruit*, consent,
RCT, trial*, and random*. Titles and abstracts were reviewed
to assess relevance. Studies with a qualitative methodology
that focused on recruitment or informed consent in any RCT
were included. As this article focuses on the recruitment
activity of healthcare professionals, studies focusing solely
on patient experiences of RCTs were not included (studies
that included perspectives of both patients and recruiters
were included, with only the latter reported in the
synthesis). All types of healthcare professionals (ie,
clinicians and nurses) were included. Only articles in
English were reviewed. Studies in paediatric trials were
excluded. No studies were excluded by quality. Reference
lists of the retrieved articles were also examined for
additional relevant articles, and newly published studies
that were identified as relevant whilst the review was being
prepared were included.
The first and senior author discussed which papers
should be included in the review until agreement was
achieved and, in total, 35 articles were selected. Quality
was assessed using the Critical Appraisal Skills Programme
checklist [22] by two reviewers (D.E. and S.H.). Individual
assessments were compared and any areas of discrepancy
were resolved by discussion. Figure 1 presents each step of
the literature search and selection process of articles, and
the full search strategy is available (see Supplementary
material).
3. Evidence synthesis
3.1. Summary of included papers
Thirty-five qualitative studies [13,23–56] were included in
the review. Many studies (23/35) explored recruitment
issues within the context of a single RCT [13,23–25,30–
33,36–40,42,44,46–48,51–54,56], whilst eight provided a
synthesis of results from multiple RCTs [26–28,41,45,49,
50,55]. Four studies sampled healthcare professionals who
recruited to RCTs generally, rather than a specific trial
[29,34,35,43]. Overall, the quality of these studies was good
(see Supplementary material), although common method-
ological issues revolved around whether data analysis was
sufficiently rigorous (it was sometimes not clear if
saturation was achieved or if multiple researchers had
analysed data to enhance reliability of the findings).
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Recruiters were from urological cancer trials [13,23,25,
27,28,40,41,44,55], other cancer trials [24,27,28,32,35,40,44,
49,50,52,54,55], mental health [27, 28, 39,46,50,55], ortho-
paedics [31,33,38,49,56], diabetes [36,47], vascular surgery
[40,49], peripartum trials [37,53], HIV [30], smoking
cessation [42], and pressure area care [51]. The majority
of studies (32/35) focused on RCTs that were conducted in
the UK [13,24–29,31–41,43–56].
Studies consisted mostly of interviews or focus groups
with those involved in recruitment to RCTs [13,23–
37,39,42–44,46–56], sometimes alongside interviews with
patients who had been offered the opportunity to join the
trial [23–26,33,37]. Several studies audio recorded con-
sultations where recruiters discussed the RCT with eligible
patients [13,24–26,31,32,38,40,41,44,45,49,50,52,55]. A
summary of the included studies is shown in Table 2.
3.2. Part 1: why is recruitment so challenging?
3.2.1. Exploring facilitators and barriers to recruitment
Overall, interviews with healthcare professionals highlight-
ed a number of positive aspects of being involved in
research. For instance, recruiters described how intellectual
challenges and professional kudos were incentives to
participate in RCTs [30,43]. Many felt that participation
in trials was beneficial in that it provided patients with
access to novel treatments [29,30,34,39,43,51], gave
patients hope [29,30], and monitored participants closely
[30,39,43].
The majority of studies used interviews to understand
recruiters’ perceptions of factors that impacted upon
recruitment to RCTs. Many described how collaboration
within the clinical team was vital [29,34,35,51,54]. Aware-
ness and understanding of the particular RCT was also
deemed to be important [29,33,39,42,43,54], particularly in
terms of the eligibility criteria [34,35,39] and study
processes [35,36,39]. Many recruiters felt that receiving
regular updates and feedback from the trial team was
beneficial [34,35,47], although some found this overwhelm-
ing [36].
Recruiters highlighted a range of logistical and practical
issues that had made recruitment challenging (Table 1).
Many commented on a lack of eligible patients
Fig. 1 – Steps of the literature search and selection process of articles. RCT = randomised controlled trial.
Table 1 – Commonly reported barriers to recruitment
Recruitment issue References
Lack of eligible patients [24,27,36,44,52,53]
Patients dislike concept of
randomisation
[24,25,27,35,50,52]
Patients express strong preferences
for a particular treatment
[23–25,32,35,44,52,53]
Lack of clinician time for
research activities
[23,29,33,34,36,39,42,43,46,47,51,53]
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Table 2 – Summary of the included studies
Study Research setting Qualitative methods
Bill-Axelson et al (2009) [23] Main study comparing radical prostatectomy with active monitoring
for prostate cancer in Sweden
Interviews with patients (n = 9) and clinicians (n = 5)
Blazeby et al (2009) [24] Feasibility study comparing chemoradiation versus chemotherapy
and surgery for oesophageal cancer in the UK
Interviews with patients (n = 14)
RCT consultations recorded (n = 26)
Donovan et al (2009) [25] Feasibility/main study comparing prostatectomy, radiotherapy, and
active monitoring for prostate cancer in UK
Interviews with recruiters and patients
RCT consultations recorded
Donovan et al (2014) [27] Six UK RCTs in a range of clinical contexts, with different types of RCT
interventions, with a range of primary recruiters, and at different
stages of the implementation of the RCT
Interviews with clinicians and nurses (n = 72)
Donovan et al (2014) [28] Six UK RCTs in a range of clinical contexts, with different types of RCT
interventions, with a range of primary recruiters, and at different
stages of the implementation of the RCT
Interviews with clinicians (n = 32)
French et al (2016) [29] Specialist nurses from a variety of research studies (including RCTs) in
general adult acute care or community settings in the UK
Interviews with specialist nurses (n = 12)
Hales et al (2001) [30] RCT for an HIV drug in Australia Interviews with clinicians (n = 10)
Grifﬁn et al (2016) [31] Feasibility study comparing surgery and nonoperative care for hip
impingement in the UK
Interviews with TMG (n = 10) and clinicians (n = 21)
RCT consultations recorded (n = 87)
Hamilton et al (2013) [32] Feasibility study comparing surgery or radiotherapy for laryngeal
cancer in the UK
Interviews with clinicians and research nurses
RCT consultations recorded
Horwood et al (2016) [33] Main study comparing intraoperative local anaesthetic wound
inﬁltration or usual care for joint pain in the UK
Interviews with patients (n = 24) and clinicians/nurses
(n = 15)
Lamb et al (2016) [34] Community nurses involved in wound care trials in the UK Interviews with research nurses (n = 8)
Langley et al (2000) [35] Clinicians recruiting to cancer trials in the UK Interviews with clinicians (n = 20)
Lawton et al (2015) [36] Type 1 diabetes main RCT comparing multiple daily injections or
pump therapy in the UK
Interviews with clinicians and nurses (n = 18)
Lawton et al (2016) [37] Peripartum pilot RCT comparing drug with placebo in the UK Interviews with clinicians/nurses (n = 27) and patients
(n = 22)
Mann et al (2014) [38] Pilot study comparing intraoperative local anaesthetic wound
inﬁltration or usual care for joint pain in the UK
RCT consultations recorded (n = 53)
Mason et al (2007) [39] Main study comparing types of antidepressants for depression RCT in
the UK
Interviews with recruiting GPs (n = 41)
Mills et al (2014) [40] Feasibility/main study comparing prostatectomy, radiotherapy, and
active monitoring for prostate cancer in the UK and two anonymised
RCTs
RCT consultations recorded (n = 103)
Mills et al (2011) [41] Feasibility/main study comparing prostatectomy, radiotherapy, and
active monitoring for prostate cancer in the UK
RCT consultations recorded (n = 93)
McIntosh et al (2005) [42] Smoking cessation trial in the USA Focus groups with clinicians (n = 30)
Newington et al (2014) [43] Clinicians and nurses involved in research (including RCTs) in the UK Interviews with clinicians and nurses (n = 11)
Paramasivan et al (2011) [44] Feasibility study comparing surgery with radiotherapy for bladder
cancer in the UK
Interviews with clinicians/nurses (n = 9) and TMG (n = 2)
RCT consultations recorded (n = 4)
Paramasivan et al (2015) [45] Two anonymised UK RCTs differed in clinical contexts and complexity
of the recruitment process
Interviews with clinicians/nurses (n = 20) and patients
(n = 23)
RCT consultations recorded (n = 35)
Patterson et al (2010) [46] Main RCT comparing art therapy with usual care for schizophrenia in
the UK
Interviews and focus groups with clinicians (n = 17)
Potter et al (2009) [47] Main RCT comparing telephone support with usual care for type
2 diabetes in the UK
Interviews with nurses (n = 10)
Potter et al (2014) [48] Hypothetical feasibility RCT in breast reconstruction after
mastectomy for breast cancer in the UK
Interviews with clinicians (n = 31)
Rooshenas et al (2016) [49] Six UK RCTs in a range of clinical contexts, with different types of RCT
interventions, with a range of primary recruiters, and at different
stages of the implementation of the RCT
Interviews with clinicians (n = 23)
RCT consultations recorded (n = 105)
de Salis et al (2008) [50] Five UK RCTs in a range of clinical contexts, with different types of
RCT interventions, with a range of primary recruiters, and at different
stages of the implementation of the RCT
Interviews with clinicians and nurses
RCT consultations recorded
Spilsbury et al (2008) [51] Main RCT comparing alternating pressure mattress overlays and
replacements
Focus group with nurses (n = 9)
Stein et al (2016) [52] Feasibility RCT comparing test direct chemotherapy versus usual care
in the UK
Interviews with clinicians and nurses (n = 14)
RCT consultations recorded (n = 36)
Stuart et al (2015) [53] Main RCT comparing home-based support with usual care for
pregnant women in the UK
Interviews with community midwives (n = 13)
Strong et al (2016) [54] Feasibility study comparing chemoradiation versus chemotherapy
and surgery for oesophageal cancer in the UK
Interviews with clinicians (n = 21)
Tomlin et al (2014) [55] Five UK RCTs in a range of clinical contexts, with different types of
RCT interventions, with a range of primary recruiters, and at different
stages of the implementation of the RCT
Interviews and focus groups with nurses (n = 43)
RCT consultations recorded (n = 23)
Wade et al (2009) [13] Feasibility/main study comparing prostatectomy, radiotherapy, and
active monitoring for prostate cancer in the UK
RCT consultations recorded (n = 23)
Zeibland et al (2007) [56] Main study comparing spinal rehabilitation with surgery for
treatment of chronic back pain in the UK
Interviews with clinicians (n = 11)
GP = general practitioner; RCT = randomised controlled trial; TMG = trial management group.
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[24,27,36,44,52,53], and that eligible patients often disliked
the concept of randomisation [24,25,27,35,50,52] or had
strong treatment preferences for particular interventions
[23–25,32,35,44,52,53]. Recruiters also described lack of
time as a key barrier to recruiting to RCTs [23,29,33,34,
36,39,42,43,46,47,51,53].
However, some studies suggested that even when
logistical and organisational issues were addressed, recruit-
ment continued to be challenging [27,28,46]. Indeed,
several recent studies have highlighted that there may be
more deep-rooted reasons as to why recruitment can be
difficult. These relate to complex emotional and intellectual
issues, which may—albeit unintentionally—affect recruit-
ment, and are described below.
3.2.2. Misunderstanding RCT concepts and design
Whilst recruiters acknowledge the importance of evidence-
based practice [23,29,34,35,39,43,56], most have not had
formal training [27,38,55] and can show poor understanding
of RCT methods and concepts [27,29,35,46,48,51,56]. For
instance, interviews with surgeons who had recently
completed recruitment to a multicentre, pragmatic RCT
comparing a rehabilitation programme with surgery for
treatment of chronic low back pain showed that they had
misunderstandings about the trial design. Many did not
understand the concept of equipoise, were unclear about the
trial’s aims, and were not aware of the rationale for the
pragmatic inclusion criteria [56].
Given this, it is perhaps not surprising that recruiters can
find it challenging to communicate with patients about
trials [23–25,30,31,35,38,44,52], can find it difficult to
articulate the trial design in simple terms [24,31,44,52], and
struggle to explain randomisation [24,25]. Furthermore,
studies have showed that recruitment consultations tend to
be led by the recruiter and predominately cover the topics
that they deem important to discuss [13,38,55]. This means
that there is often insufficient evidence for the recruiter to
judge the participant’s level of understanding or willingness
to join the trial. It has instead been suggested that
information provision should be tailored to the patient’s
concerns and questions, and that specific communication
techniques—such as using open questions and pauses, and
enabling the patient to interrupt—provide opportunities for
the patient to discuss what is important to them [13].
3.2.3. Emotional challenges of dual roles
Several studies alluded to the complexities of combining
research with clinical roles [23,26–30,36,39,42,43,48,50–
52,55]. Findings from interviews with recruiting staff from
six RCTs showed that whilst they expressed strong commit-
ment to the RCT and research in general, clinicians and nurses
experienced emotional and intellectual challenges related to
their roles as scientists and clinicians [27,28]. Clinicians
described themselves as scientists or practicing clinicians,
with some combining both. Nurses identified themselves as
having three major roles: caring clinical nurse, patient
advocate, and recruiter/scientist. As both groups discussed
their roles and the challenges and conflicts within them, they
expressed emotion and discomfort. Lawton and colleagues
[36] have also highlighted the emotional challenges that
could arise from the conflicting priorities of their research
roles and clinical responsibilities. In these studies, most
recruiters had not raised these issues with chief investigators
(CIs) and colleagues, and were unaware how their views
contributed to recruitment difficulties.
3.2.4. Discomfort with RCT eligibility criteria
The synthesis by Donovan and colleagues [27] found that
within their research roles, clinicians were typically respon-
sible for eligibility assessments of patients and nurses had
considerable influence over which eligible patients to
approach. Clinicians often described reluctance to recruit
particular patients or groups of patients who fitted the
eligibility criteria for the RCT but were perceived to be
‘‘unsuitable’’ for other reasons. Most nurses expressed their
right to use clinical judgement to decide whom to approach
about the RCT. In some trials, when they approached patients,
they had a tendency to become awkward and apologise for
‘‘bothering’’ potential patients about the trial. These findings
were also identified in part in several single RCT studies
reporting that recruiters may not approach all eligible
patients [23,30,32,34,35,39,43,44,46–48,52,53,56]. Taken to-
gether, this means that many eligible patients will not have
had the opportunity to consider RCT participation.
3.2.5. Lack of equipoise between RCT treatment options
‘‘Community equipoise’’ refers to the principle that there is
uncertainty or disagreement in the clinical community
about which treatment is best [57], whilst ‘‘individual
equipoise’’ exists when an individual is uncertain about
treatment superiority [58]. Interviews have suggested that
recruiters can find it difficult to be in individual equipoise
and instead favour a particular treatment arm in an RCT
[23–25,27,28,31,32,38,44,45,47,49,52,54]. Donovan and
colleagues [28] found that clinicians, particularly surgeons,
had ‘‘hunches’’ that particular treatments were superior in
general or for specific patients or groups. The conflict
between the wish to gain robust evidence and personal
preferences created considerable discomfort in some cases.
Using data from six RCTs, Rooshenas et al [49] interviewed
23 clinicians to understand their intentions for communicat-
ing equipoise, and audio recorded 105 of their consultations
where they presented the RCT to eligible patients. Interviews
revealed that clinicians expressed different levels of uncer-
tainty, ranging from complete ambivalence to clear beliefs
that one treatment was superior. Irrespective of their
personal views, all clinicians intended to set their personal
biases aside to convey trial treatments neutrally to patients.
However, analysis of the consultations demonstrated that
equipoise was omitted or compromised in 46% of the
recorded appointments, by clinicians offering treatment
recommendations, presenting imbalanced descriptions of
trial treatments, or disclosing their personal opinions or
predictions about trial outcomes [49].
3.2.6. Difficulty exploring patient preferences
Across many studies, recruiters reported that patients
declined RCT participation because they held strong
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treatment preferences for particular interventions [23–
25,27,32,35,44,52,53]. Aside from recruiter influences,
patient preferences can be informed by a number of factors,
including information and advice from family and friends
[25] and the media [25]. Mills and colleagues [41]
conducted an analysis of audio recordings of recruitment
appointments with 93 participants in a trial of localised
prostate cancer treatments. Patient preferences ranged
from hesitant opinions to well-formed intentions to receive
a particular treatment. These preferences frequently
changed after detailed discussion of treatments and trial
rationale with recruitment staff. However, several studies
have highlighted that recruiters can feel uncomfortable
exploring these further [24,32,40,44,52] and are more likely
to accept patient preferences if they align with the
recruiter’s own views [27,28].
3.2.7. Identifying specific recruitment issues in RCTs
Whilst the challenges identified are commonly reported
across a range of RCTs, it is important to note that the degree
that these issues are present and the extent that they affect
recruitment will inevitably vary between RCTs. For in-
stance, whilst recruiters often struggle to feel comfortable
with the concept of uncertainty between trial arms, training
and support strategies can sometimes help overcome this so
that recruitment targets are met [25]. In other instances, the
lack of recruiter equipoise has been so fundamental that the
RCT had to be closed [32].
In addition to these common themes, each RCT will have
a set of unique issues that need to be resolved [50]. Urologi-
cal RCTs often involve complicated pathways that can be
particularly lengthy, and include many different healthcare
professionals or multiple centres [44]. The availability and
evidence base for treatment options outside of each RCT will
vary (particularly within fields such as urology, where there
are rapidly changing treatment options [23]), which may
have implications for clinician equipoise. Some RCTs may
also have complex designs, making them even more
difficult to discuss with patients. For instance, recruiters
from one urological trial had to explain the need for
neoadjuvant chemotherapy, the timing of randomisation in
relation to the cycles of chemotherapy, and two extremely
different treatment arms (surgery to remove the cancer and
bladder, or a selective bladder preservation technique that
involved radiotherapy to destroy the cancer and preserve
the bladder except where the tumour persisted when
surgery was recommended) [44].
3.3. Part 2: what solutions are there to recruitment difficulties?
3.3.1. Developing training programmes for those recruiting to trials
Taken together, the previous section has highlighted the
need for training and support for recruiters (both for generic
and RCT-specific issues). Only a relatively small number of
studies have used qualitative research to develop training
for those recruiting patients into RCTs [24,26,31,32,38,44,
50,52]. One study developed a peer-review training
programme, whereby four research nurses from an
orthopaedic pilot study provided regular feedback on each
other’s recorded RCT consultations. All the nurses felt that
communication and recruitment abilities were improved,
and stated that they would want to repeat this process in
subsequent trials [38].
The other interventions identified had originated from
the ProtecT study, whereby a complex intervention was
developed to improve rates of randomisation and informed
consent [25]. Table 3 summarises the key issues identified
and strategies implemented to overcome these. This
intervention has since been refined in a number of RCTs
[24,26,31,32,44,50,52], and the final version of the QuinteT
Recruitment Intervention (QRI) is conducted in two phases.
Phase 1 aims to understand the trial recruitment process by
Table 3 – Issues identified in the ProtecT study and strategies to improve recruitment [25]
1. Organisation and presentation of study information
Treatments tended to be presented in a standard order: surgery, radiotherapy, and then active monitoring. Analysis showed that these options were not
presented equally. Recruiters were asked to present the treatments in a different order [(1) active monitoring, (2) surgery, and (3) radiotherapy] and to
describe their advantages and disadvantages.
2. Terminology used in study information
The term ‘‘trial’’ was sometimes interpreted as monitoring (‘‘try and see’’), so recruiters were asked to use ‘‘study’’ instead. Recruiters had tried to reassure
patients that there was a good 10-yr survival (‘‘the majority of men with prostate cancer will be alive 10 yr later’’). However, patients interpreted this to
suggest that they might die in 10 yr. It was recommended that recruiters present survival in terms of ‘‘most men with prostate cancer live long lives’’.
3. Speciﬁcation and presentation of the nonradical arm
Recruiters often called the non-radical arm ‘‘watchful waiting,’’ but patients had interpreted this as ‘‘no treatment’’, where the disease would be
watched and the patient waited for death (‘‘watch while I die’’). This was renamed ‘‘active monitoring’’ and redeﬁned to involve three monthly or six
monthly prostate speciﬁc antigen tests, with intervention if required or requested.
4. Presentation of randomisation and equipoise
Both recruiters and patients had difﬁculty with randomisation and equipoise. Recruiters were supported to feel comfortable discussing uncertainty
and explaining that patients were suitable for all three treatments. They were also advised to explain the rationale for randomisation and explain that
if the patient were uncertain, randomisation represented a way of resolving the dilemma of treatment choice.
5. Exploring patient preferences
Recruiters initially felt uncomfortable discussing patient preferences. Training emphasised that it was important to elicit and explore preferences,
particularly if these were not well founded in evidence (eg, rejecting radiotherapy because of a mistaken belief that it would lead to hair loss).
ProtecT = Prostate Testing for Cancer and Treatment trial.
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conducting in-depth interviews with healthcare profes-
sionals involved in recruitment and patients approached
about the study, audio recording recruitment discussions,
analysing screening log data to understand patient pathways,
observing study meetings, and reviewing study documenta-
tion, with rapid analysis of findings and reporting to the CI
and trial management group (TMG). In phase 2, the QRI team
works collaboratively with the CI and TMG to implement
strategies to improve recruitment (see Fig. 2) [26]. To date,
these methods have been implemented in 25 RCTs. The QRI
has optimised methods that enable recruitment to be
completed in feasibility/pilot or main RCTs [25,26,
31,52]. In other instances, the QRI has provided detailed
evidence to support a decision to cease recruitment [32].
3.3.2. Challenges of integrating qualitative research in RCTs
Whilst these methods produce important insights about
recruitment practices, the challenges of integrating quali-
tative research with RCTs has been well documented. For
instance, recruiters are often reluctant to provide audio
recordings of consultations [24,26,38,44,50,52]. If the
qualitative research is integrated into an RCT where
recruitment is already ongoing, the process of obtaining
additional ethical approval can be lengthy [26]. It has
therefore been suggested that qualitative work should be
integrated structurally and culturally into the RCT, ideally
before recruitment begins and at the feasibility stage, in
order to produce the greatest results [50].
3.3.3. Future directions for research
It is important to note that current interventions are limited
by the availability of only observational evidence of their
effectiveness, therefore limiting the ability to determine
causality between interventions and recruitment rates
[26]. A recent review has identified the need to develop
more robust designs to develop an evidence base on how
best to support recruiters [59]. More robust studies are
needed to assess the effectiveness of training programmes,
although these will need to give careful consideration to
how ‘‘successful’’ interventions should be defined (ie,
completion of study or evidence to support closure) and
what the outcomes should be (ie, screening and eligibility
counts, recruitment rates, or changes in informed consent).
Furthermore, given that research has demonstrated that
patients can find RCT concepts confusing [14–17], it is
important not to neglect the patient’s perspective of the
recruitment process, and to further develop methods to
facilitate joint decision making and ensure fully informed
consent.
4. Conclusions
Many fundamental questions in the management of
patients in most specialities remain unanswered, and RCTs
are required to provide high-quality evidence to support
clinical decision making. Recruitment difficulties were
often attributed to logistical issues (such as a lack of time
for research activities) or patient-related factors (including
strong treatment preferences or disliking randomisation).
In 2012, Fletcher and colleagues [18] highlighted the
potential of using qualitative research to understand
recruitment, and since this, qualitative studies have shed
further light on the challenges of recruiting patients [24,26–
29,31–34,36–38,40,43,45,48,49,52–54]. Taken together,
these highlight how recruitment is a complex and fragile
process in which recruiters can experience emotional and
Fig. 2 – Overview of the QuinteT Recruitment Intervention. a Actions are mandatory.
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intellectual challenges related to their dual roles of
researchers and clinicians. This role conflict may (uninten-
tionally) affect recruitment in a number ways, for example,
by creating difficulty conveying equipoise, discomfort with
the eligibility criteria, and exploring patient preferences.
Therefore, there is a need to develop training and support
programmes to enable recruiters to become more comfort-
able with the design and principles of RCTs. Donovan and
colleagues [28] state that this should include ensuring that
recruiters understand and can communicate key aspects of
the RCT design, and how to gently explore patients’
preferences. It has also been suggested that nurses and
doctors who recruit to RCTs require different training and
support. Doctors may benefit from support in relation to
assessments of eligibility and equipoise [28], whereas nurses
require support for perceived conflicts in their roles as a
recruiter, patient advocate, and clinician, and for helping
them to be comfortable with approaching all patients [27].
Whilst common themes haven been identified in this
review, each RCT will have a set of unique issues that need
to be resolved. In urology RCTs, this may include lengthy
patient pathways, complex designs, and rapidly changing
treatment options. Only a small number of training
programmes have been developed from issues identified
by qualitative methods [24,26,31,32,38,44,50,52]. Most of
these have been QRIs [24,26,31,32,44,50,52], which consist
of in-depth investigation of recruitment obstacles in real
time, followed by implementation of tailored strategies to
address these challenges as the trial proceeds. These
interventions have optimised practices that enable recruit-
ment to be completed in feasibility/pilot or main RCTs, or
have provided detailed evidence to support a decision to
cease recruitment. The multifaceted and flexible nature of
qualitative research can provide important insights into the
complexities of recruiting to trials so that subsequent
interventions can be developed, although quantitative
research would be more suited to rigorously evaluating
such programmes to determine the components that can
lead to improved recruitment and informed consent in
RCTs.
In summary, this article demonstrates that qualitative
research can provide important insights into the complexi-
ties of recruitment to trials, which can inform support and
training initiatives as required. Investigators should con-
sider implementing such methods in urological RCTs that
are expected to be challenging or are recruiting below target
to tackle the most challenging clinical questions facing
patients and clinicians.
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